Dietary microplastics promote gut inflammation leading to prolonged viral arthritis

Prof Andreas Suhrbier leads the Inflammation Biology group at QIMR Berghofer MRI.  He did his undergraduate at Oxford University, UK (1978-82), his PhD at Southampton University, UK (1982-5), his first post doc at Imperial College of Science and Technology, London, UK (1986-1989) and came to Australia in 1990 on Wellcome Trust Fellowship .  Since 2004 he has been a Research Fellow with the NHMRC, and currently holds an Investigator Grant (Impact option; 100% economic).  He is co-director of the Australian Infectious Disease Research Centre.  He has 185 publications and is an inventor on 19 patents.  His research is primarily focused on understanding pathology of, and developing interventions for, pathogenic viruses, primarily via development, characterisation and exploitation of mouse models.  He has extensive experience with PC3/BSL3 management, and holds Defence Export Control permits for several highly pathogenic viruses on the Defence and Strategic Goods List.  He regularly undertakes consultancies and R&D research in collaboration with industry partners, with his publications very highly cited in the patent literature (PatCite).  His group has recently established a SARS-CoV-2 PC3 suite at QIMR Berghofer, with the K18-hACE2 mouse model successfully being used to test a range of new interventions (drugs, vaccines, biologics) in collaboration with a number of academic and industry partners.